Cubist Systematic Strategies, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 183,490 shares of RARE stock, worth $8.03 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
183,490
Holding current value
$8.03 Million
% of portfolio
0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$40.21 - $59.36 $7.38 Million - $10.9 Million
183,490 New
183,490 $10.2 Million
Q1 2024

May 15, 2024
BUY
$43.02 - $53.69 $973,585 - $1.22 Million
22,631 New
22,631 $1.06 Million
Q3 2023

Nov 14, 2023
SELL
$34.92 - $46.66 $4.65 Million - $6.21 Million
-133,156 Reduced 82.03%
29,178 $1.04 Million
Q2 2023

Aug 14, 2023
SELL
$37.35 - $52.15 $2.64 Million - $3.68 Million
-70,634 Reduced 30.32%
162,334 $7.49 Million
Q1 2023

May 15, 2023
BUY
$36.99 - $48.71 $287,375 - $378,427
7,769 Added 3.45%
232,968 $9.34 Million
Q4 2022

Feb 14, 2023
SELL
$33.72 - $46.33 $653,493 - $897,875
-19,380 Reduced 7.92%
225,199 $10.4 Million
Q3 2022

Nov 14, 2022
BUY
$39.96 - $66.14 $9.24 Million - $15.3 Million
231,245 Added 1734.25%
244,579 $10.1 Million
Q2 2022

Aug 15, 2022
SELL
$45.8 - $85.4 $1.23 Million - $2.29 Million
-26,819 Reduced 66.79%
13,334 $796,000
Q1 2022

May 16, 2022
BUY
$62.2 - $84.4 $2.05 Million - $2.78 Million
32,913 Added 454.6%
40,153 $2.92 Million
Q4 2021

Feb 14, 2022
SELL
$73.71 - $87.86 $2.37 Million - $2.83 Million
-32,208 Reduced 81.65%
7,240 $609,000
Q3 2021

Nov 15, 2021
SELL
$77.92 - $102.4 $11.2 Million - $14.7 Million
-143,360 Reduced 78.42%
39,448 $3.56 Million
Q2 2021

Aug 16, 2021
BUY
$92.19 - $115.71 $13.7 Million - $17.2 Million
148,274 Added 429.36%
182,808 $17.4 Million
Q1 2021

May 17, 2021
SELL
$106.9 - $167.73 $4.14 Million - $6.49 Million
-38,715 Reduced 52.85%
34,534 $3.93 Million
Q4 2020

Feb 16, 2021
BUY
$84.4 - $177.39 $3.32 Million - $6.97 Million
39,317 Added 115.87%
73,249 $10.1 Million
Q3 2020

Nov 16, 2020
BUY
$72.98 - $90.0 $2.48 Million - $3.05 Million
33,932 New
33,932 $2.79 Million
Q2 2020

Aug 14, 2020
SELL
$46.91 - $78.22 $509,583 - $849,703
-10,863 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$33.8 - $62.9 $307,343 - $571,949
-9,093 Reduced 45.57%
10,863 $483,000
Q4 2019

Feb 14, 2020
SELL
$36.08 - $45.83 $625,843 - $794,967
-17,346 Reduced 46.5%
19,956 $852,000
Q3 2019

Nov 14, 2019
BUY
$42.5 - $63.11 $1.46 Million - $2.17 Million
34,396 Added 1183.62%
37,302 $1.6 Million
Q2 2019

Aug 14, 2019
BUY
$54.93 - $74.36 $159,626 - $216,090
2,906 New
2,906 $185,000
Q1 2019

May 15, 2019
SELL
$39.87 - $69.36 $794,569 - $1.38 Million
-19,929 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$38.89 - $77.3 $455,363 - $905,105
11,709 Added 142.45%
19,929 $867,000
Q3 2018

Nov 14, 2018
BUY
$71.81 - $90.15 $590,278 - $741,033
8,220 New
8,220 $628,000
Q2 2018

Aug 14, 2018
SELL
$48.54 - $85.31 $125,815 - $221,123
-2,592 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$44.33 - $58.52 $141,191 - $186,386
-3,185 Reduced 55.13%
2,592 $132,000
Q4 2017

Feb 14, 2018
SELL
$43.54 - $57.32 $152,825 - $201,193
-3,510 Reduced 37.79%
5,777 $268,000
Q3 2017

Nov 14, 2017
BUY
$49.79 - $66.32 $462,399 - $615,913
9,287
9,287 $495,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.6M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.06B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email